// SECTOR INVESTOR DOSSIER

Investors in Synthetic Biology

9 investors with active positions in Synthetic Biology unicorns — combined exposure across this sector $3B in paper valuation.

Note: combined paper valuation reflects overlapping investor positions — individual investors hold stakes in the same companies.